# Kyntra Bio, Inc.: Form 8-K, filed Jun 26, 2024

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2024-06-26
- Accepted by EDGAR: Jun 26, 2024, 12:00 ET
- Period: 2024-06-26
- Accession: 0000950170-24-077616
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000095017024077616/fgen-20240626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000095017024077616/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000095017024077616/fgen-20240626.htm

Filed Jun 26, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-077616. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.